Key Influencer in the Tuberculosis Diagnostics Market 2025: Tuberculosis Diagnostics In Response To Rising Incidence Driver

How Are the key drivers contributing to the expansion of the tuberculosis diagnostics market?
The increasing instances of tuberculosis is fuelling the need for tuberculosis diagnostics market in the future. Being an infectious disease, mainly affecting the lungs, tuberculosis can become severe. The disease spreads through sneezing and coughing, releasing minute germs into the air. Tuberculosis diagnostics assist in early detection and diagnosis of the disease. For example, the Centers for Disease Control and Prevention, a national public health agency based in the US, reported 8,300 cases of tuberculosis (TB) in March 2023, a significant increase from 7,874 cases in 2021 in the United States. Hence, the escalating prevalence of tuberculosis is propelling the tuberculosis diagnostics market. Consequently, the surge in tuberculosis cases is prompting the expansion of the tuberculosis diagnostics market.

Get Your Tuberculosis Diagnostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

What growth opportunities are expected to drive the tuberculosis diagnostics market's CAGR through 2034?
The market for tuberculosis diagnostics has seen robust growth in recent years. Its value is predicted to climb from $2.21 billion in 2024 to $2.36 billion in 2025, representing a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the historic period include an upturn in tuberculosis cases, a surge in healthcare spending, an increase in healthcare institutions and a growing acceptance of nucleic acid testing.

Over the coming years, the tuberculosis diagnostics market is projected to witness notable expansion, attaining a value of $3.24 billion by 2029 with a compound annual growth rate (CAGR) of 8.2%. Factors expected to drive this progress include robust government backing, an increase in FDA sanctions for tuberculosis diagnostics, amplified research and development undertakings, and the arrival of drug-resistant tuberculosis. During the forecast period, some of the major shifts are likely to revolve around the emphasis on next-generation sequencing (NGS) platforms for TB diagnosis, advancements in products, T-cell examinations for TB infection, the implementation of artificial intelligence (AI) in tuberculosis diagnostics, the adoption of portable gadgets, and governmental collaborations with manufacturers.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

What are the most significant trends transforming the tuberculosis diagnostics market today?
Technological advancements are becoming an increasingly prominent trend in the tuberculosis diagnostics market. Leading companies in this sphere are leveraging innovative technologies like advanced point-of-care (POC) diagnostic methods powered by AI, to maintain their market dominance. For example, in August 2022, Fujifilm, a Japanese firm specialising in the manufacture of medical imaging devices, teamed up with Qure.ai, an American company that develops AI-driven medical imaging solutions. Together, they unveiled an advanced POC diagnostic method. This method was dependent on a battery-powered X-ray machine for diagnosing tuberculosis. AI algorithms aid in effective testing procedures, providing high precision, ultra-portable, and efficient POC diagnostic solutions.

Which growth-oriented segments of the tuberculosis diagnostics market are leading the industry's development?
The tuberculosis diagnostics market covered in this report is segmented -

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8165

What regions are leading the charge in the tuberculosis diagnostics market?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the tuberculosis diagnostics market?
Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

What Is Covered In The Tuberculosis Diagnostics Global Market Report?

• Market Size Forecast: Examine the tuberculosis diagnostics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the tuberculosis diagnostics market for a structured understanding.
• Key Players Overview: Analyze major players in the tuberculosis diagnostics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the tuberculosis diagnostics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the tuberculosis diagnostics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the tuberculosis diagnostics market.
• Industry Challenges: Identify potential risks and obstacles affecting the tuberculosis diagnostics market.
• Competitive Landscape: Review strategic developments in the tuberculosis diagnostics market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.